Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

Similar articles for PubMed (Select 23613886)

1.

Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.

Hu Z, Zhou J, Wang H, Zhang M, Li S, Huang Y, Wu J, Li Z, Zhou L, Zheng S.

PLoS One. 2013 Apr 16;8(4):e61620. doi: 10.1371/journal.pone.0061620. Print 2013.

2.

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, Schwartz ME.

Ann Surg Oncol. 2000 Dec;7(10):764-70.

PMID:
11129425
3.
4.

Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.

Lee JJ, Kim PT, Fischer S, Fung S, Gallinger S, McGilvray I, Moulton CA, Wei AC, Greig PD, Cleary SP.

Ann Surg Oncol. 2014 Aug;21(8):2708-16. doi: 10.1245/s10434-014-3609-6. Epub 2014 May 8.

PMID:
24806113
5.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

6.

Liver transplantation for hepatocellular carcinoma within Milan Criteria in patients with Model for End-Stage Liver Disease score below 15: the impact of the etiology of cirrhosis on long-term survival.

Tandoi F, Ponte E, Saffioti MC, Patrono D, Mirabella S, Lupo F, Romagnoli R, Salizzoni M.

Transplant Proc. 2013 Sep;45(7):2711-4. doi: 10.1016/j.transproceed.2013.07.002.

PMID:
24034029
7.

Viral status at the time of liver transplantation for hepatocellular carcinoma: a modern predictor of longterm survival.

Groeschl RT, Hong JC, Christians KK, Turaga KK, Tsai S, Pilgrim CH, Gamblin TC.

HPB (Oxford). 2013 Oct;15(10):794-802. doi: 10.1111/hpb.12134. Epub 2013 Jun 19.

8.

α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.

Zhang Q, Shang L, Zang Y, Chen X, Zhang L, Wang Y, Wang L, Liu Y, Mao S, Shen Z.

Eur J Gastroenterol Hepatol. 2014 May;26(5):544-52. doi: 10.1097/MEG.0000000000000029.

PMID:
24614696
9.

Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.

Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.

Liver Transpl. 2004 Dec;10(12):1478-86.

10.

Histological differentiation predicts post-liver transplantation survival time.

Li WX, Li Z, Gao PJ, Gao J, Zhu JY.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):201-8. doi: 10.1016/j.clinre.2013.11.002. Epub 2013 Dec 30.

PMID:
24388339
11.

Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.

Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.

Liver Transpl. 2007 Jun;13(6):807-13.

12.

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.

Chen PH, Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Huo TI, Huang YH, Wu WC, Chao Y, Lin HC, Wu JC.

Ann Hepatol. 2013 Mar-Apr;12(2):263-73.

PMID:
23396738
13.

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.

Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME.

Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917.

PMID:
25203882
14.

The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis.

Zhang Q, Chen X, Zang Y, Zhang L, Chen H, Wang L, Niu Y, Ren X, Shen Z, Shang L.

PLoS One. 2012;7(12):e50919. doi: 10.1371/journal.pone.0050919. Epub 2012 Dec 7.

15.

Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.

Waki K, Sugawara Y, Tamura S, Mieno MN, Yamashiki N, Kadowaki T, Kokudo N.

Transplantation. 2011 Oct 15;92(7):809-14. doi: 10.1097/TP.0b013e31822d4dc3.

PMID:
21832961
16.

Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.

Dumitra S, Alabbad SI, Barkun JS, Dumitra TC, Coutsinos D, Metrakos PP, Hassanain M, Paraskevas S, Chaudhury P, Tchervenkov JI.

HPB (Oxford). 2013 Sep;15(9):724-31. doi: 10.1111/hpb.12041. Epub 2013 Mar 14.

18.

Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.

Chirica M, Tranchart H, Tan V, Faron M, Balladur P, Paye F.

Ann Surg Oncol. 2013 Jul;20(7):2405-12. doi: 10.1245/s10434-012-2861-x. Epub 2013 Jan 23.

PMID:
23338483
19.

Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.

Makarova M, Krettek A, Valkov MY, Grjibovski AM.

Int J Circumpolar Health. 2013 May 13;72:20282. doi: 10.3402/ijch.v72i0.20282. Print 2013.

20.

A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.

Hernandez-Alejandro R, Croome KP, Drage M, Sela N, Parfitt J, Chandok N, Marotta P, Dale C, Wall W, Quan D.

World J Gastroenterol. 2012 Aug 21;18(31):4145-9. doi: 10.3748/wjg.v18.i31.4145.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk